基于蛋白质的纳米颗粒用于治疗呼吸道传染病:目前的进展和未来的方向
Pamela Kadare1, Mellisa T R Chikukwa1, Marique Aucamp2
1Infectious Disease Nanomedicine Research Group, School of Pharmacy, University of the Western Cape, Bellville, Cape Town, South Africa.
Nanomedicine (London, England)
|February 25, 2026
概括
基于蛋白质的纳米粒子为抗感染药物提供创新的药物递送系统 (DDS),打击耐药性. 这些纳米颗粒显示出局部肺药物输送具有最小毒性的承诺.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 传染性疾病 传染性疾病
背景情况:
- 越来越多的感染和耐药性病原体需要先进的药物输送系统 (DDS).
- 来自各种来源的基于蛋白质的纳米粒子 (NP) 正在成为有效的DDS抗感染药物.
- 专用蛋白质,如白蛋白和乳酸,为药物输送提供了独特的优势,并具有固有的抗菌特性.
研究的目的:
- 提供基于蛋白质的NP作为抗感染药物的DDS的全面审查.
- 探索基于蛋白质的NP在呼吸道感染的肺部药物输送中的潜力.
- 突出这些新型DDS的治疗效果和安全性.
主要方法:
- 对PubMed和谷歌学者数据库的文献评论.
- 分析了2023年1月至2026年2月期间发表的研究.
- 关于NP蛋白质特性,应用和肺部输送的数据的综合.
主要成果:
- 基于蛋白质的NP证明了通过受体介导途径有效的细胞内药物递送.
- 基于乳酸的NP具有固有的抗病毒和抗菌活性.
- 通过肺部输送蛋白质NP可以达到局部,持续的药物度,具有低毒性.
结论:
- 基于蛋白质的NP代表了增强抗感染疗法的有希望的策略.
- 它们在肺部药物输送中的应用要求对呼吸道传染病进行进一步的临床研究.
- 蛋白质NP提供了潜在的安全和有效的DDS来对抗感染.
相关概念视频
Microorganisms in Medicine and Therapeutics
1.2K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.2K
Pneumonia IV: Management
868
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
868
Drugs Used in Lower Respiratory Disorders: Overview
1.3K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.3K
Pneumonia V: Nursing management and Prevention
3.7K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.7K
Acute Respiratory Failure-V
551
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
551


